市場調査レポート

商品コード

1601595

カテーテルおよび能動埋め込みデバイスのCDMOの世界市場：サービスカテゴリ・エンドユーザー・地域別の予測 (～2032年)

Global Catheters and Active Implantable CDMO Market Research Report Information by Service Category, By End-Users And By Region -Market Forecast Till 2032

出版日: 2024年11月15日
発行: Market Research Future
ページ情報: 英文 187 Pages
納期: 即納可能

価格

PDF & Excel (Single User License)

USD 4,950 727,600円

レポートPDF、Excelを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。

PDF & Excel (Multi User License)

USD 5,950 874,590円

レポートPDF、Excelを同一企業内の最大15名がご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。

PDF & Excel (Enterprise License)

USD 7,250 1,065,677円

レポートPDF、Excelを同一企業内のすべての方がご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDF、Excelの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.99円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

カテーテルおよび能動埋め込みデバイスのCDMOの市場規模は、2023年の69億2,000万米ドル、2024年の74億9,000万米ドルから、予測期間中は10.82%のCAGRで推移し、2032年には188億米ドルに拡大すると予測されています。

市場拡大の原動力となっているのは、カテーテルおよび能動埋め込みデバイスのCDMOに関連した戦略的イニシアチブの増加や、製造アウトソーシングの増加です。

イニシアチブの高まりは技術革新を促進し、市場アクセシビリティを向上させ、同市場を大幅に押し上げています。戦略的M&Aにより、組織は包括的なソリューションを提供できるようになり、リソースや知識を結集して製品開発を加速できるようになっています。同時に、特に新興国における医療インフラへの投資の増加や、侵襲の少ない手技への嗜好の高まりにより、先進的なカテーテルや埋め込みデバイスの使用が増加しています。

地域別インサイト

北米地域は2023年に最大の市場シェアを占め、予測期間中も成長が見込まれています。一方、アジア太平洋地域は予測期間中にもっとも速いCAGRで成長すると予測されています。

北米市場は、技術開発、良好な規制環境、ヘルスケア需要の高まりにより急速に拡大しています。さらに、洗練された医療インフラと研究開発への多額の投資が市場を牽引しており、これにより最先端の埋め込みデバイスの開発が可能となっています。さらに、新興諸国への展開の可能性、オーダーメイド治療の台頭、低侵襲ソリューションへの需要が成長の道筋を示しています。

欧州市場は、技術の進歩とヘルスケア需要の高まりにより、大きな成長の可能性を秘めています。次世代心臓ペースメーカー、神経刺激装置、インスリンポンプなどの埋め込みデバイス技術の向上が、専門的な製造能力に対する需要を押し上げています。高齢化によって慢性疾患の頻度が高まっていることも、複雑で高品質な埋め込みによる治療への需要を高めています。

アジア太平洋市場は著しい成長を見せ、予測期間を通じてもっとも急成長する地域と予測されています。いくつかの重要な促進要因が力強い成長を促しています。医療技術の急速な向上や、中国、インド、日本などの国における医療インフラへの投資の増加が、高度な埋め込みデバイスの需要を促進しています。慢性疾患、糖尿病の有病率の増加、高齢化により、新規治療薬への需要が高まっています。

当レポートでは、世界のカテーテルおよび能動埋め込みデバイスのCDMOの市場を調査し、市場の定義と概要、市場成長への各種影響因子の分析、市場規模の推移・予測、各種区分・地域/主要国別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

概要
カテーテル
- 心臓カテーテル
- 泌尿器科カテーテル
- 神経血管カテーテル
- その他
能動埋め込みデバイス
- 神経調節デバイス
- 構造的心臓デバイス
- 心不全デバイス
- 泌尿器科用埋め込みデバイス
- その他
内視鏡デバイス
その他

第7章カテーテルおよび能動埋め込みデバイスのCDMO市場：エンドユーザー別

概要
医療機器OEM企業
学術研究機関
政府機関

第8章カテーテルおよび能動埋め込みデバイスのCDMO市場：地域別

概要
北米
- 米国
- カナダ
欧州
- ドイツ
- フランス
- 英国
- イタリア
- スペイン
- その他
アジア太平洋
- 中国
- インド
- 日本
- 韓国
- オーストラリア
- その他
その他の地域
- 中東・アフリカ
- 南米

第9章競合情勢

市場シェア分析
競合ダッシュボード
公開企業の株式概要
比較分析：主要企業の財務動向
主な展開と成長戦略

第10章企業プロファイル

INTEGER HOLDINGS CORPORATION
CIRTEC
BIOMERICS
SWITCHBACK MEDICAL
VELENTIUM LLC
HERAEUS GROUP
ZEUS COMPANY LLC
VERANEX
FREUDENBERG MEDICAL
MEDEOLOGIX
DATA CITATIONS

図表

LIST OF TABLES

TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT
TABLE 1 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY SERVICE CATEGORY, 2018-2032 (USD MILLION)
TABLE 2 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR CATHETERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 3 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR CATHETERS, BY TYPE, 2018-2032 (USD MILLION)
TABLE 4 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR CARDIAC CATHETERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 5 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR UROLOGY CATHETERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 6 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR NEUROVASCULAR CATHETERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 7 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR OTHERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 8 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ACTIVE IMPLANTABLE DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 9 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ACTIVE IMPLANTABLE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
TABLE 10 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR NEUROMODULATION DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 11 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR NEUROMODULATION DEVICES, BY TYPE, 2018-2032 (USD MILLION)
TABLE 12 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR SPINAL CORD STIMULATORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 13 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR DEEP BRAIN STIMULATORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 14 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR OTHERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 15 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR STRUCTURAL HEART DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 16 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR STRUCTURAL HEART DEVICES, BY TYPE, 2018-2032 (USD MILLION)
TABLE 17 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR VALVE IMPLANTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 18 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR STENTS & SHUNTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 19 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR OTHERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 20 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR HEART FAILURE DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 21 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR HEART FAILURE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
TABLE 22 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR PERCUTANEOUS LEFT VENTRICULAR ASSIST DEVICE (LVAD), BY REGION, 2018-2032 (USD MILLION)
TABLE 23 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR PERCUTANEOUS RIGHT VENTRICULAR SUPPORT DEVICES (RVAD), BY REGION, 2018-2032 (USD MILLION)
TABLE 24 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR OTHERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 25 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR UROLOGY IMPLANTABLE DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 26 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR OTHERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 27 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ENDOSCOPY DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 28 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR OTHERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 29 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY END USER, 2018-2032 (USD MILLION)
TABLE 30 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR MEDICAL DEVICE OEM COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 31 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 32 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR GOVERNMENT AGENCIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 33 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY REGION, 2019-2032 (USD MILLION)
TABLE 34 NORTH AMERICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35 NORTH AMERICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY SERVICE CATEGORY, 2018-2032 (USD MILLION)
TABLE 36 NORTH AMERICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR CATHETERS, BY TYPE, 2018-2032 (USD MILLION)
TABLE 37 NORTH AMERICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ACTIVE IMPLANTABLE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
TABLE 38 NORTH AMERICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR NEUROMODULATION DEVICES, BY TYPE, 2018-2032 (USD MILLION)
TABLE 39 NORTH AMERICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR STRUCTURAL HEART DEVICES, BY TYPE, 2018-2032 (USD MILLION)
TABLE 40 NORTH AMERICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR HEART FAILURE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
TABLE 41 NORTH AMERICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY END USER, 2018-2032 (USD MILLION)
TABLE 42 US: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY SERVICE CATEGORY, 2018-2032 (USD MILLION)
TABLE 43 US: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR CATHETERS, BY TYPE, 2018-2032 (USD MILLION)
TABLE 44 US: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ACTIVE IMPLANTABLE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
TABLE 45 US: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR NEUROMODULATION DEVICES, BY TYPE, 2018-2032 (USD MILLION)
TABLE 46 US: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR STRUCTURAL HEART DEVICES, BY TYPE, 2018-2032 (USD MILLION)
TABLE 47 US: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR HEART FAILURE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
TABLE 48 US: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY END USER, 2018-2032 (USD MILLION)
TABLE 49 CANADA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY SERVICE CATEGORY, 2018-2032 (USD MILLION)
TABLE 50 CANADA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR CATHETERS, BY TYPE, 2018-2032 (USD MILLION)
TABLE 51 CANADA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ACTIVE IMPLANTABLE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
TABLE 52 CANADA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR NEUROMODULATION DEVICES, BY TYPE, 2018-2032 (USD MILLION)
TABLE 53 CANADA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR STRUCTURAL HEART DEVICES, BY TYPE, 2018-2032 (USD MILLION)
TABLE 54 CANADA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR HEART FAILURE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
TABLE 55 CANADA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY END USER, 2018-2032 (USD MILLION)
TABLE 56 EUROPE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57 EUROPE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY SERVICE CATEGORY, 2018-2032 (USD MILLION)
TABLE 58 EUROPE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR CATHETERS, BY TYPE, 2018-2032 (USD MILLION)
TABLE 59 EUROPE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ACTIVE IMPLANTABLE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
TABLE 60 EUROPE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR NEUROMODULATION DEVICES, BY TYPE, 2018-2032 (USD MILLION)
TABLE 61 EUROPE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR STRUCTURAL HEART DEVICES, BY TYPE, 2018-2032 (USD MILLION)
TABLE 62 EUROPE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR HEART FAILURE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
TABLE 63 EUROPE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY END USER, 2018-2032 (USD MILLION)
TABLE 64 GERMANY: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY SERVICE CATEGORY, 2018-2032 (USD MILLION)
TABLE 65 GERMANY: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR CATHETERS, BY TYPE, 2018-2032 (USD MILLION)
TABLE 66 GERMANY: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ACTIVE IMPLANTABLE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
TABLE 67 GERMANY: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR NEUROMODULATION DEVICES, BY TYPE, 2018-2032 (USD MILLION)
TABLE 68 GERMANY: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR STRUCTURAL HEART DEVICES, BY TYPE, 2018-2032 (USD MILLION)
TABLE 69 GERMANY: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR HEART FAILURE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
TABLE 70 GERMANY: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY END USER, 2018-2032 (USD MILLION)
TABLE 71 FRANCE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY SERVICE CATEGORY, 2018-2032 (USD MILLION)
TABLE 72 FRANCE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR CATHETERS, BY TYPE, 2018-2032 (USD MILLION)
TABLE 73 FRANCE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ACTIVE IMPLANTABLE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
TABLE 74 FRANCE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR NEUROMODULATION DEVICES, BY TYPE, 2018-2032 (USD MILLION)
TABLE 75 FRANCE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR STRUCTURAL HEART DEVICES, BY TYPE, 2018-2032 (USD MILLION)
TABLE 76 FRANCE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR HEART FAILURE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
TABLE 77 FRANCE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY END USER, 2018-2032 (USD MILLION)
TABLE 78 UK: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY SERVICE CATEGORY, 2018-2032 (USD MILLION)
TABLE 79 UK: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR CATHETERS, BY TYPE, 2018-2032 (USD MILLION)
TABLE 80 UK: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ACTIVE IMPLANTABLE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
TABLE 81 UK: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR NEUROMODULATION DEVICES, BY TYPE, 2018-2032 (USD MILLION)
TABLE 82 UK: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR STRUCTURAL HEART DEVICES, BY TYPE, 2018-2032 (USD MILLION)
TABLE 83 UK: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR HEART FAILURE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
TABLE 84 UK: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY END USER, 2018-2032 (USD MILLION)
TABLE 85 ITALY: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY SERVICE CATEGORY, 2018-2032 (USD MILLION)
TABLE 86 ITALY: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR CATHETERS, BY TYPE, 2018-2032 (USD MILLION)
TABLE 87 ITALY: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ACTIVE IMPLANTABLE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
TABLE 88 ITALY: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR NEUROMODULATION DEVICES, BY TYPE, 2018-2032 (USD MILLION)
TABLE 89 ITALY: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR STRUCTURAL HEART DEVICES, BY TYPE, 2018-2032 (USD MILLION)
TABLE 90 ITALY: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR HEART FAILURE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
TABLE 91 ITALY: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY END USER, 2018-2032 (USD MILLION)
TABLE 92 SPAIN: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY SERVICE CATEGORY, 2018-2032 (USD MILLION)
TABLE 93 SPAIN: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR CATHETERS, BY TYPE, 2018-2032 (USD MILLION)
TABLE 94 SPAIN: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ACTIVE IMPLANTABLE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
TABLE 95 SPAIN: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR NEUROMODULATION DEVICES, BY TYPE, 2018-2032 (USD MILLION)
TABLE 96 SPAIN: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR STRUCTURAL HEART DEVICES, BY TYPE, 2018-2032 (USD MILLION)
TABLE 97 SPAIN: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR HEART FAILURE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
TABLE 98 SPAIN: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY END USER, 2018-2032 (USD MILLION)
TABLE 99 REST OF EUROPE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY SERVICE CATEGORY, 2018-2032 (USD MILLION)
TABLE 100 REST OF EUROPE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR CATHETERS, BY TYPE, 2018-2032 (USD MILLION)
TABLE 101 REST OF EUROPE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ACTIVE IMPLANTABLE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
TABLE 102 REST OF EUROPE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR NEUROMODULATION DEVICES, BY TYPE, 2018-2032 (USD MILLION)
TABLE 103 REST OF EUROPE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR STRUCTURAL HEART DEVICES, BY TYPE, 2018-2032 (USD MILLION)
TABLE 104 REST OF EUROPE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR HEART FAILURE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
TABLE 105 REST OF EUROPE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY END USER, 2018-2032 (USD MILLION)
TABLE 106 ASIA-PACIFIC: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 107 ASIA-PACIFIC: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY SERVICE CATEGORY, 2018-2032 (USD MILLION)
TABLE 108 ASIA-PACIFIC: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR CATHETERS, BY TYPE, 2018-2032 (USD MILLION)
TABLE 109 ASIA-PACIFIC: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ACTIVE IMPLANTABLE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
TABLE 110 ASIA-PACIFIC: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR NEUROMODULATION DEVICES, BY TYPE, 2018-2032 (USD MILLION)
TABLE 111 ASIA-PACIFIC: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR STRUCTURAL HEART DEVICES, BY TYPE, 2018-2032 (USD MILLION)
TABLE 112 ASIA-PACIFIC: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR HEART FAILURE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
TABLE 113 ASIA-PACIFIC: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY END USER, 2018-2032 (USD MILLION)
TABLE 114 CHINA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY SERVICE CATEGORY, 2018-2032 (USD MILLION)
TABLE 115 CHINA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR CATHETERS, BY TYPE, 2018-2032 (USD MILLION)
TABLE 116 CHINA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ACTIVE IMPLANTABLE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
TABLE 117 CHINA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR NEUROMODULATION DEVICES, BY TYPE, 2018-2032 (USD MILLION)
TABLE 118 CHINA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR STRUCTURAL HEART DEVICES, BY TYPE, 2018-2032 (USD MILLION)
TABLE 119 CHINA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR HEART FAILURE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
TABLE 120 CHINA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY END USER, 2018-2032 (USD MILLION)
TABLE 121 INDIA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY SERVICE CATEGORY, 2018-2032 (USD MILLION)
TABLE 122 INDIA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR CATHETERS, BY TYPE, 2018-2032 (USD MILLION)
TABLE 123 INDIA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ACTIVE IMPLANTABLE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
TABLE 124 INDIA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR NEUROMODULATION DEVICES, BY TYPE, 2018-2032 (USD MILLION)
TABLE 125 INDIA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR STRUCTURAL HEART DEVICES, BY TYPE, 2018-2032 (USD MILLION)
TABLE 126 INDIA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR HEART FAILURE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
TABLE 127 INDIA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY END USER, 2018-2032 (USD MILLION)
TABLE 128 JAPAN: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY SERVICE CATEGORY, 2018-2032 (USD MILLION)
TABLE 129 JAPAN: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR CATHETERS, BY TYPE, 2018-2032 (USD MILLION)
TABLE 130 JAPAN: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ACTIVE IMPLANTABLE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
TABLE 131 JAPAN: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR NEUROMODULATION DEVICES, BY TYPE, 2018-2032 (USD MILLION)
TABLE 132 JAPAN: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR STRUCTURAL HEART DEVICES, BY TYPE, 2018-2032 (USD MILLION)
TABLE 133 JAPAN: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR HEART FAILURE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
TABLE 134 JAPAN: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY END USER, 2018-2032 (USD MILLION)
TABLE 135 SOUTH KOREA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY SERVICE CATEGORY, 2018-2032 (USD MILLION)
TABLE 136 SOUTH KOREA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR CATHETERS, BY TYPE, 2018-2032 (USD MILLION)
TABLE 137 SOUTH KOREA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ACTIVE IMPLANTABLE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
TABLE 138 SOUTH KOREA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR NEUROMODULATION DEVICES, BY TYPE, 2018-2032 (USD MILLION)
TABLE 139 SOUTH KOREA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR STRUCTURAL HEART DEVICES, BY TYPE, 2018-2032 (USD MILLION)
TABLE 140 SOUTH KOREA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR HEART FAILURE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
TABLE 141 SOUTH KOREA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY END USER, 2018-2032 (USD MILLION)
TABLE 142 AUSTRALIA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY SERVICE CATEGORY, 2018-2032 (USD MILLION)
TABLE 143 AUSTRALIA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR CATHETERS, BY TYPE, 2018-2032 (USD MILLION)
TABLE 144 AUSTRALIA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ACTIVE IMPLANTABLE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
TABLE 145 AUSTRALIA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR NEUROMODULATION DEVICES, BY TYPE, 2018-2032 (USD MILLION)
TABLE 146 AUSTRALIA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR STRUCTURAL HEART DEVICES, BY TYPE, 2018-2032 (USD MILLION)
TABLE 147 AUSTRALIA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR HEART FAILURE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
TABLE 148 AUSTRALIA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY END USER, 2018-2032 (USD MILLION)
TABLE 149 REST OF ASIA-PACIFIC: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY SERVICE CATEGORY, 2018-2032 (USD MILLION)
TABLE 150 REST OF ASIA-PACIFIC: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR CATHETERS, BY TYPE, 2018-2032 (USD MILLION)
TABLE 151 REST OF ASIA-PACIFIC: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ACTIVE IMPLANTABLE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
TABLE 152 REST OF ASIA-PACIFIC: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR NEUROMODULATION DEVICES, BY TYPE, 2018-2032 (USD MILLION)
TABLE 153 REST OF ASIA-PACIFIC: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR STRUCTURAL HEART DEVICES, BY TYPE, 2018-2032 (USD MILLION)
TABLE 154 REST OF ASIA-PACIFIC: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR HEART FAILURE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
TABLE 155 REST OF ASIA-PACIFIC: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY END USER, 2018-2032 (USD MILLION)
TABLE 156 REST OF THE WORLD: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 157 REST OF THE WORLD: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY SERVICE CATEGORY, 2018-2032 (USD MILLION)
TABLE 158 REST OF THE WORLD: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR CATHETERS, BY TYPE, 2018-2032 (USD MILLION)
TABLE 159 REST OF THE WORLD: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ACTIVE IMPLANTABLE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
TABLE 160 REST OF THE WORLD: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR NEUROMODULATION DEVICES, BY TYPE, 2018-2032 (USD MILLION)
TABLE 161 REST OF THE WORLD: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR STRUCTURAL HEART DEVICES, BY TYPE, 2018-2032 (USD MILLION)
TABLE 162 REST OF THE WORLD: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR HEART FAILURE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
TABLE 163 REST OF THE WORLD: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY END USER, 2018-2032 (USD MILLION)
TABLE 164 MIDDLE EAST & AFRICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY SERVICE CATEGORY, 2018-2032 (USD MILLION)
TABLE 165 MIDDLE EAST & AFRICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR CATHETERS, BY TYPE, 2018-2032 (USD MILLION)
TABLE 166 MIDDLE EAST & AFRICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ACTIVE IMPLANTABLE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
TABLE 167 MIDDLE EAST & AFRICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR NEUROMODULATION DEVICES, BY TYPE, 2018-2032 (USD MILLION)
TABLE 168 MIDDLE EAST & AFRICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR STRUCTURAL HEART DEVICES, BY TYPE, 2018-2032 (USD MILLION)
TABLE 169 MIDDLE EAST & AFRICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR HEART FAILURE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
TABLE 170 MIDDLE EAST & AFRICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY END USER, 2018-2032 (USD MILLION)
TABLE 171 SOUTH AMERICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY SERVICE CATEGORY, 2018-2032 (USD MILLION)
TABLE 172 SOUTH AMERICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR CATHETERS, BY TYPE, 2018-2032 (USD MILLION)
TABLE 173 SOUTH AMERICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ACTIVE IMPLANTABLE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
TABLE 174 SOUTH AMERICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR NEUROMODULATION DEVICES, BY TYPE, 2018-2032 (USD MILLION)
TABLE 175 SOUTH AMERICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR STRUCTURAL HEART DEVICES, BY TYPE, 2018-2032 (USD MILLION)
TABLE 176 SOUTH AMERICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR HEART FAILURE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
TABLE 177 SOUTH AMERICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY END USER, 2018-2032 (USD MILLION)
TABLE 178 FACILITY EXPANSION
TABLE 179 ACQUISITION
TABLE 180 PARTNERSHIP
TABLE 181 INTEGER HOLDINGS CORPORATION: PRODUCT OFFERED
TABLE 182 INTEGER HOLDINGS CORPORATION: KEY DEVELOPMENTS
TABLE 183 CIRTEC: PRODUCTS OFFERED
TABLE 184 CIRTEC: KEY DEVELOPMENTS
TABLE 185 BIOMERICS: PRODUCTS OFFERED
TABLE 186 BIOMERICS: KEY DEVELOPMENTS
TABLE 187 SWITCHBACK MEDICAL: PRODUCTS OFFERED
TABLE 188 VELENTIUM LLC: PRODUCTS OFFERED
TABLE 189 HERAEUS GROUP: PRODUCTS OFFERED
TABLE 190 ZEUS COMPANY LLC: PRODUCTS OFFERED
TABLE 191 VERANEX: PRODUCTS OFFERED
TABLE 192 FREUDENBERG MEDICAL: PRODUCTS OFFERED
TABLE 193 MEDEOLOGIX: PRODUCTS OFFERED

LIST OF FIGURES

FIGURE 1 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET: STRUCTURE
FIGURE 2 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET: MARKET GROWTH FACTOR ANALYSIS (2023-2032)
FIGURE 3 DRIVER IMPACT ANALYSIS (2023-2032)
FIGURE 4 RESTRAINT IMPACT ANALYSIS (2023-2032)
FIGURE 5 PORTER'S FIVE FORCES ANALYSIS: GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET
FIGURE 6 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, SERVICE CATEGORY, 2023 & 2032 (USD MILLION)
FIGURE 7 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY SERVICE CATEGORY, 2023 & 2032 (USD MILLION)
FIGURE 8 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET SHARE (%), BY SERVICE CATEGORY,
FIGURE 9 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, END USER, 2023 & 2032 (USD MILLION)
FIGURE 10 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY END USER, 2023 & 2032 (USD MILLION)
FIGURE 11 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET SHARE (%), BY END USER,
FIGURE 12 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY REGION, 2023 & 2032 (USD MILLION)
FIGURE 13 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET SHARE (%), BY REGION,
FIGURE 14 NORTH AMERICA MARKET ANALYSIS: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, 2018-2032
FIGURE 15 NORTH AMERICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY COUNTRY, 2023 & 2032 (USD MILLION)
FIGURE 16 NORTH AMERICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET SHARE (%), BY COUNTRY,
FIGURE 17 EUROPE MARKET ANALYSIS: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, 2018-2032 (USD MILLION)
FIGURE 18 EUROPE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET SHARE, BY COUNTRY, 2023 & 2032 (USD MILLION)
FIGURE 19 EUROPE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET SHARE, BY COUNTRY, 2023 (%)
FIGURE 20 ASIA-PACIFIC MARKET ANALYSIS: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, 2019-2032 (USD MILLION)
FIGURE 21 ASIA-PACIFIC: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET SHARE, BY COUNTRY, 2023 & 2032 (USD MILLION)
FIGURE 22 ASIA-PACIFIC: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET SHARE, BY COUNTRY, 2023 (%)
FIGURE 23 REST OF THE WORLD MARKET ANALYSIS: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, 2018-2032 (USD MILLION)
FIGURE 24 REST OF THE WORLD: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET SHARE, BY COUNTRY, 2023 & 2032 (USD MILLION)
FIGURE 25 REST OF THE WORLD: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET SHARE, BY COUNTRY, 2023 (%)
FIGURE 26 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET PLAYERS: COMPETITIVE ANALYSIS,
FIGURE 27 COMPETITOR DASHBOARD: GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET
FIGURE 28 INTEGER HOLDINGS CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 29 INTEGER HOLDINGS CORPORATION: SWOT ANALYSIS
FIGURE 30 CIRTEC: SWOT ANALYSIS
FIGURE 31 SWITCHBACK MEDICAL: SWOT ANALYSIS
FIGURE 32 HERAEUS GROUP: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 33 HERAEUS GROUP: SWOT ANALYSIS
FIGURE 34 ZEUS COMPANY LLC: SWOT ANALYSIS

Product Code: MRFR/HC/25126-CR

Global Catheters and Active Implantable CDMO Market Research Report Information by Service Category (Catheters, Active Implantable Devices, Endoscopy Devices, and Others), By End-Users (Medical Device OEM Companies, Academic and Research Institutes, and Government Agencies) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) -Market Forecast Till 2032

Market Overview

The Catheters and Active Implantable CDMO Market was valued at USD 6.92 billion in 2023. The market is expected to increase from USD 7.49 billion in 2024 to USD 18.8 billion by 2032, with a compound annual growth rate (CAGR) of 10.82% for the forecast period (2024-2032).

The market expansion is being driven by increased strategic initiatives connected with catheters and active implantable CDMO, as well as increased production outsourcing.

Growing initiatives are promoting innovation and enhancing market accessibility, significantly boosting the global market for catheters and active implanted CDMOs. Strategic mergers and acquisitions enable organizations to offer comprehensive solutions and accelerate product development by pooling resources and knowledge. Simultaneously, the use of advanced catheters and implantable devices is increasing as a result of increased investments in healthcare infrastructure, particularly in emerging nations, and a growing preference for less intrusive procedures.

Market Segment insights

The Catheters and Active Implantable CDMO Market is divided into three service segments: catheters, active implantable devices, and endoscopy devices.

The Catheters and Active Implantable CDMO Market is divided into three end user segments: medical device OEM firms, academic and research organizations, and government agencies.

Regional insights

North America held the biggest market share in 2023 and is expected to grow over the forecast period. However, Asia-Pacific is expected to develop at the fastest CAGR over the forecast period.

The Active Implantable CDMO market in North America is expanding rapidly, owing to technical developments, a favorable regulatory environment, and rising healthcare demands. Furthermore, the market is driven by sophisticated healthcare infrastructure and significant investment in R&D, which allows for the development of cutting-edge implantable devices. Furthermore, potential for development into emerging countries, the rise of customized treatment, and the demand for minimally invasive solutions offer paths for growth.

The Americas region is followed by Europe, which is further divided into Germany, France, the United Kingdom, Italy, Spain, and the Rest of Europe. The Active Implantable CDMO market in Europe has great growth potential, driven by technological advancements and rising healthcare demands. Implantable device technology improvements, such as next-generation cardiac pacemakers, neurostimulators, and insulin pumps, are driving up demand for specialized manufacturing capabilities. The rising frequency of chronic diseases, fueled by an aging population, heightens the demand for complex, high-quality implantable treatments.

Asia-Pacific is predicted to show significant growth and is projected to be the fastest growing region throughout the projection period. Several important drivers are driving robust growth. Rapid improvements in medical technology, as well as increased investment in healthcare infrastructure in nations such as China, India, and Japan, are driving demand for advanced implantable devices. The increased prevalence of chronic diseases, diabetes, and an aging population increase the demand for novel remedies.

Major Players

Major competitors in the Catheters and Active Implantable CDMO Market include Integer Holdings Corporation (US), Cirtec (US), Biomerics (US), Switchback Medical (US), Velentium LLC (US), Heraeus Group (Germany), Zeus Company LLC (US), Veranex (US), Freudenberg Medical (US), and Medeologix (Taiwan).

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.3 RESEARCH OBJECTIVE
2.4 MARKET STRUCTURE

3 RESEARCH METHODOLOGY

3.1 OVERVIEW
3.2 DATA FLOW
- 3.2.1 Data Mining Process
3.3 PURCHASED DATABASE:
3.4 SECONDARY SOURCES:
- 3.4.1 Secondary Research data flow:
3.5 PRIMARY RESEARCH:
- 3.5.1 Primary Research DATA FLOW:
- 3.5.2 Primary Research: Number of Interviews conducted
- 3.5.3 Primary Research: Regional Coverage
3.6 APPROACHES FOR MARKET SIZE ESTIMATION:
- 3.6.1 Revenue Analysis Approach
3.7 DATA FORECASTING
- 3.7.1 Data forecasting Technique
3.8 DATA MODELING
- 3.8.1 microeconomic factor analysis:
- 3.8.2 Data modeling:
3.9 TEAMS AND ANALYST CONTRIBUTION

4 MARKET DYNAMICS

4.1 INTRODUCTION
4.2 DRIVERS
- 4.2.1 Increasing strategic initiatives associated with Catheters and Active Implantable CDMO
- 4.2.2 Increased Outsourcing of Manufacturing
4.3 RESTRAINTS
- 4.3.1 Stringent regulatory Policies
4.4 OPPORTUNITY
- 4.4.1 Growing geriatric population across the globe
- 4.4.2 FACILITY EXPANSION by Contract Development Manuacturing Organization

5 MARKET FACTOR ANALYSIS

5.1 PORTER'S FIVE FORCES MODEL
- 5.1.1 Threat of New Entrants
- 5.1.2 Bargaining Power of Suppliers
- 5.1.3 Threat of Substitutes
- 5.1.4 Bargaining Power of Buyers
- 5.1.5 Intensity of Rivalry
5.2 IMPACT OF COVID-19 ON THE GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET
5.3 TRENDS IN CDMO FOR CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET
- 5.3.1 Shifting Focus of Medical Device CDMOs to Improve Capabilities

6 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY SERVICE CATEGORY

6.1 OVERVIEW
6.2 CATHETERS
- 6.2.1 Cardiac Catheters
- 6.2.2 Urology Catheters
- 6.2.3 Neurovascular Catheters
- 6.2.4 Others
6.3 ACTIVE IMPLANTABLE DEVICES
- 6.3.1 Neuromodulation Devices
  - 6.3.1.1 Spinal Cord Stimulators
  - 6.3.1.2 Deep Brain Stimulators
  - 6.3.1.3 Others
- 6.3.2 Structural Heart Devices
  - 6.3.2.1 Valve Implants
  - 6.3.2.2 Stents & Shunts
  - 6.3.2.3 Others
- 6.3.3 Heart Failure Devices
  - 6.3.3.1 Percutaneous Left Ventricular Assist Device (LVAD)
  - 6.3.3.2 Percutaneous Right Ventricular Support Devices (RVAD)
  - 6.3.3.3 Others
- 6.3.4 Urology Implantable Devices
- 6.3.5 Others
6.4 ENDOSCOPY DEVICES
6.5 OTHERS

7 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY END USER

7.1 OVERVIEW
7.2 MEDICAL DEVICE OEM COMPANIES
7.3 ACADEMIC AND RESEARCH INSTITUTES
7.4 GOVERNMENT AGENCIES

8 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY REGION

8.1 OVERVIEW
8.2 NORTH AMERICA
- 8.2.1 US
- 8.2.2 Canada
8.3 EUROPE
- 8.3.1 Germany
- 8.3.2 France
- 8.3.3 UK
- 8.3.4 Italy
- 8.3.5 Spain
- 8.3.6 Rest of Europe
8.4 ASIA-PACIFIC
- 8.4.1 China
- 8.4.2 India
- 8.4.3 Japan
- 8.4.4 South Korea
- 8.4.5 Australia
- 8.4.6 Rest of Asia-Pacific
8.5 REST OF THE WORLD
- 8.5.1 Middle East & Africa
- 8.5.2 South America

9 COMPETITIVE LANDSCAPE

9.1 INTRODUCTION
9.2 MARKET SHARE ANALYSIS,
9.3 COMPETITOR DASHBOARD
9.4 PUBLIC PLAYERS STOCK SUMMARY
9.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL
9.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
- 9.6.1 Facility expansion
- 9.6.2 Acquisition
- 9.6.3 Partnership

10 COMPANY PROFILES

10.1 INTEGER HOLDINGS CORPORATION
- 10.1.1 COMPANY OVERVIEW
- 10.1.2 FINANCIAL OVERVIEW
- 10.1.3 productS OFFERED
- 10.1.4 KEY DEVELOPMENTS
- 10.1.5 SWOT ANALYSIS
- 10.1.6 KEY STRATEGIES
10.2 CIRTEC
- 10.2.1 COMPANY OVERVIEW
- 10.2.2 FINANCIAL OVERVIEW
- 10.2.3 PRODUCT OFFERED
- 10.2.4 KEY DEVELOPMENTS
- 10.2.5 SWOT ANALYSIS
- 10.2.6 KEY STRATEGIES
10.3 BIOMERICS
- 10.3.1 COMPANY OVERVIEW
- 10.3.2 FINANCIAL OVERVIEW
- 10.3.3 PRODUCTS OFFERED
- 10.3.4 KEY DEVELOPMENTS
- 10.3.5 KEY STRATEGIES
10.4 SWITCHBACK MEDICAL
- 10.4.1 COMPANY OVERVIEW
- 10.4.2 FINANCIAL OVERVIEW
- 10.4.3 PRODUCTS OFFERED
- 10.4.4 KEY DEVELOPMENTS
- 10.4.5 SWOT ANALYSIS
- 10.4.6 KEY STRATEGIES
10.5 VELENTIUM LLC
- 10.5.1 COMPANY OVERVIEW
- 10.5.2 FINANCIAL OVERVIEW
- 10.5.3 PRODUCTS OFFERED
- 10.5.4 KEY DEVELOPMENTS
- 10.5.5 KEY STRATEGIES
10.6 HERAEUS GROUP
- 10.6.1 COMPANY OVERVIEW
- 10.6.2 FINANCIAL OVERVIEW
- 10.6.3 PRODUCTS OFFERED
- 10.6.4 KEY DEVELOPMENTS
- 10.6.5 SWOT ANALYSIS
- 10.6.6 KEY STRATEGIES
10.7 ZEUS COMPANY LLC
- 10.7.1 COMPANY OVERVIEW
- 10.7.2 FINANCIAL OVERVIEW
- 10.7.3 PRODUCTS OFFERED
- 10.7.4 KEY DEVELOPMENTS
- 10.7.5 SWOT ANALYSIS
- 10.7.6 KEY STRATEGIES
10.8 VERANEX
- 10.8.1 COMPANY OVERVIEw
- 10.8.2 FINANCIAL OVERVIEW
- 10.8.3 Product OFFERed
- 10.8.4 KEY DEVELOPMENTS
- 10.8.5 KEY STRATEGIES
10.9 FREUDENBERG MEDICAL
- 10.9.1 COMPANY OVERVIEW
- 10.9.2 FINANCIAL OVERVIEW
- 10.9.3 PRODUCTS OFFERED
- 10.9.4 KEY DEVELOPMENTS
- 10.9.5 KEY STRATEGIES
10.10 MEDEOLOGIX
- 10.10.1 COMPANY OVERVIEW
- 10.10.2 FINANCIAL OVERVIEW
- 10.10.3 PRODUCTS OFFERED
- 10.10.4 KEY DEVELOPMENTS
- 10.10.5 KEY STRATEGIES
10.11 DATA CITATIONS

カテーテルおよび能動埋め込みデバイスのCDMOの世界市場：サービスカテゴリ・エンドユーザー・地域別の予測 (～2032年)

Global Catheters and Active Implantable CDMO Market Research Report Information by Service Category, By End-Users And By Region -Market Forecast Till 2032

目次

第1章エグゼクティブサマリー

第2章市場概要

第3章調査手法

第4章市場力学

第5章市場要因分析

第6章カテーテルおよび能動埋め込みデバイスのCDMO市場：サービスカテゴリ別

第7章カテーテルおよび能動埋め込みデバイスのCDMO市場：エンドユーザー別

第8章カテーテルおよび能動埋め込みデバイスのCDMO市場：地域別

第9章競合情勢

第10章企業プロファイル

LIST OF TABLES

LIST OF FIGURES

Market Overview

Major Players

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

3 RESEARCH METHODOLOGY

4 MARKET DYNAMICS

5 MARKET FACTOR ANALYSIS

6 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY SERVICE CATEGORY

7 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY END USER

8 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY REGION

9 COMPETITIVE LANDSCAPE

10 COMPANY PROFILES

カテーテルおよび能動埋め込みデバイスのCDMOの世界市場：サービスカテゴリ・エンドユーザー・地域別の予測 (～2032年)

Global Catheters and Active Implantable CDMO Market Research Report Information by Service Category, By End-Users And By Region -Market Forecast Till 2032

目次

第1章 エグゼクティブサマリー

第2章 市場概要

第3章 調査手法

第4章 市場力学

第5章 市場要因分析

第6章 カテーテルおよび能動埋め込みデバイスのCDMO市場：サービスカテゴリ別

第7章 カテーテルおよび能動埋め込みデバイスのCDMO市場：エンドユーザー別

第8章 カテーテルおよび能動埋め込みデバイスのCDMO市場：地域別

第9章 競合情勢

第10章 企業プロファイル

LIST OF TABLES

LIST OF FIGURES

Market Overview

Major Players

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

3 RESEARCH METHODOLOGY

4 MARKET DYNAMICS

5 MARKET FACTOR ANALYSIS

6 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY SERVICE CATEGORY

7 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY END USER

8 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY REGION

9 COMPETITIVE LANDSCAPE

10 COMPANY PROFILES

第1章エグゼクティブサマリー

第2章市場概要

第3章調査手法

第4章市場力学

第5章市場要因分析

第6章カテーテルおよび能動埋め込みデバイスのCDMO市場：サービスカテゴリ別

第7章カテーテルおよび能動埋め込みデバイスのCDMO市場：エンドユーザー別

第8章カテーテルおよび能動埋め込みデバイスのCDMO市場：地域別

第9章競合情勢

第10章企業プロファイル